Filing Details
- Accession Number:
- 0001203311-23-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-18 19:04:06
- Reporting Period:
- 2023-05-16
- Accepted Time:
- 2023-05-18 19:04:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1809717 | R Charles Romp | 21823 30Th Drive Se Bothell WA 98021 | Evp, Commercial U.s. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-05-16 | 349 | $189.86 | 59,777 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a written plan adopted on November 3, 2020 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.